Reliably resilient
CATALENT
FROM FM GLOBAL'S 2020 ANNUAL REPORT
And with the prospect that millions of vaccines would soon be needed, expansion of Catalent’s facility in Bloomington, Indiana, USA, took on a whole new urgency. The expansion, which included construction of a new building as well as the installation and validation of new equipment, would typically take two years. It needed to be done in just eight months.
Catalent wasn’t just redefining resilience, it was accelerating it. Catalent had looked to
FM Global for guidance on meeting the high standards of its customers for more than
10 years. In Bloomington, that meant ensuring resilience wasn’t sacrificed for speed.
FM Global engineers were at the ready. They accelerated plan reviews, making sure their process didn’t slow down the project. Local FM Global engineers were on-site whenever needed and their familiarity with local contractors helped speed the process even more.
“We have considerable experience in facility and capacity expansion in Bloomington,” explains Tejal Karia, Calatent’s head of global risk management. “It was the combined experience of our team and the FM Global team working together that allowed us to accelerate this project. Together, we made sure that it was absolutely done the right way.”
Today, Catalent is supporting 80 COVID-19-related compounds, including several of the leading vaccines, tests and treatments. Many of those compounds are flowing through the newly expanded Bloomington facility.
Bloomington is just the latest example of FM Global and Catalent working together to ensure the supply of critical medications and treatments that are relied on by millions across the globe.
Bloomington was already a model facility before the expansion, earning Facility of the Year honors in both 2007 and 2017 from the International Society of Pharmaceutical Engineers. It was, and remains, a highly protected risk (HPR), the highest standard of resilience at FM Global. It is just one of many HPR facilities in Catalent’s portfolio.
By March of last year, the coronavirus pandemic had a firm hold on the world.
It quickly became clear that it would take a vaccine to finally quell the virus. Pharmaceutical companies were already hard at work.
At its facility in St. Petersburg, Florida, USA, Catalent invested more than US$2 million to upgrade its ignitable liquid storage capabilities. The massive 453,000-square-foot (42,000-square-meter) complex is the company’s primary softgel development and manufacturing facility, capable of producing 18 billion capsules a year.
In Swindon, U.K., Catalent invested in additional sprinkler protection at the 253,000-square-foot
(23,500-square-meter) facility that houses its Zydis fast-dissolving tablet development and manufacturing operation. Catalent has chosen to invest in risk improvement at many of its other key locations as well. The list includes its Kansas City, Missouri, USA, site, home to the Center of Excellence for its biologics analytical services business, and the Center of Excellence for sterile liquid fill and finishing processes in Woodstock, Illinois, USA.
“Risk mitigation is a priority for us,” Karia adds. “We need to deliver our products in a timely manner, without disruption and with the highest standards of quality. Risk mitigation and loss prevention are common goals for Catalent and FM Global, which is what makes it such a great partnership.”
So too was Catalent. A vital linchpin in the manufacturing and distribution of pharmaceutical products, Catalent serves nearly every major pharmaceutical, biologics and consumer health product company in the industry.
Head of Global Risk Management, Catalent
TEJAL KARIA
The fact that our facilities are well protected provides
further assurance of our ability to be a trusted partner
for our customers, and ultimately the patients who rely on our treatments.
“We believe our customers value how we maintain and operate our facilities,” Karia adds. “The fact that our facilities are well protected provides further assurance of our ability to be a trusted partner for our customers, and ultimately the patients who rely on our treatments.”
And to remain that trusted partner, Catalent has chosen to invest millions of U.S. dollars to redefine resilience at many of its key locations.
© 2021 FM Global. All rights reserved.
Contact an FM Global representative.
Connect with us
Keep me informed
Subscribe to your choice of
FM Global’s eNewsletters.
STAY IN TOUCH
86 of the top 100 branded drug companies
24 of the top 25 generics companies
23 of the top 25 biologics companies
22 of the top 25 consumer health companies
CATALENT SERVES:
THE SUPPLY CHAIN
CHALLENGE
Covid vaccines pose the
ultimate challenge to
supply chain resilience.
READ MORE
Read how FM Global helped bring Hershey’s Malaysian facility on line.
READ MORE
TO ASIA WITH LOVE
FM Global's knowledge and experience help our clients tackle everything from chocolate factories in Malaysia to supply chain resilience.
MORE FOR YOU
Download CATALENT PROFILE
Good project planning, and the right insurance coverage, can help you minimize risk during new construction or renovation.
READ MORE
PROJECT SERVICES
®
© 2021 FM Global. All rights reserved.
Keep me informed
Subscribe to your choice of
FM Global’s monthly eNewsletters.
Contact an FM Global representative.
Connect with us
STAY IN TOUCH
See what’s available through
FM Global’s Learning Center.
READ MORE
FM GLOBAL LEARNING CENTER
Read how a Research Campus trip
inspired Land O’Lakes.
READ MORE
Hello flood
Learn more about the
FM Global Research Campus.
READ MORE
FM GLOBAL RESEARCH CAMPUS
Learn more about FM Global’s clients,
products and services.
MORE FOR YOU
Cookie Notice